AVENUE THERAPTC Revenue, Profits - ATXI Quarterly Income Statement

Add to My Stocks
$3.27 $0.26 (7.37%) ATXI stock closing price Sep 19, 2018 (Closing)

Looking at financial statements, along with the AVENUE THERAPTC stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q2 impacts the ATXI stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at AVENUE THERAPTC assets, operating expenses and AVENUE THERAPTC free cash flow. The AVENUE THERAPTC profit and loss statement shows revenue of $- for 2018 Q2. Revenue has decreased by 0 QoQ for ATXI stock.

View and download details of revenue and profits for AVENUE THERAPTC for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q32016 Q2
AVENUE THERAPTC Revenues or Net Sales
--------
Cost Of Goods Sold (COGS)--------
AVENUE THERAPTC Gross Profit
--------
Research & Development Expense3.75M9.43M5.23M2M----
Selling General & Admin Expense--1.12M-1.29M---
Income Before Depreciation Depletion Amortization-4.68M-10.42M-6.34M-2.84M-1.74M-0.5M-0.38M-0.63M
Depreciation Depletion Amortization--------
Non Operating Income-----0.54M--0.01M-
Interest Expense--------
AVENUE THERAPTC Pretax Income
-4.66M-10.37M-6.25M-2.94M-2.4M-0.66M-0.54M-0.77M
Provision for Income Taxes--------
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-4.66M-10.38M-6.24M-2.95M-2.41M-0.66M-0.54M-0.77M
Extraordinary Items & Discontinued Operations--------
AVENUE THERAPTC Profit/ Loss (Net Income)
-4.66M-10.38M-6.24M-2.95M-2.41M-0.66M-0.54M-0.77M
Average Shares used to compute Diluted EPS10.25M10.1M9.97M9.97M3.46M---
Average Shares used to compute Basic EPS10.25M10.1M9.97M9.97M3.46M---
Income Before Nonrecurring Items-4.66M-10.38M-6.24M-2.95M-1.86M---
Income from Nonrecurring Items-----0.55M---
AVENUE THERAPTC Earnings Per Share Basic Net
-0.45-1.03-0.63-0.30-0.70---
AVENUE THERAPTC Earnings Per Share Diluted Net
-0.45-1.03-0.63-0.30-0.70---
EPS Diluted Before Nonrecurring Items-0.45-1.03-0.63-0.30-0.54---
Preferred Dividends Acc Pd--------
Dividends Common0.000.000.00-----
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on AVENUE THERAPTC stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2018 Q2. Our AVENUE THERAPTC revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-4.66M for AVENUE THERAPTC for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The ATXI financials along with AVENUE THERAPTC historical stock prices provide a lot of details about the firm.

AVENUE THERAPTC Income Statement - Key Financial Ratios